Published in Br J Clin Pharmacol on February 01, 1977
Comparison of propranolol and metoprolol in the management of hyperthyroidism. Br J Clin Pharmacol (1979) 1.00
Left ventricular function in hypothyroidism. Responses to exercise and beta adrenoceptor blockade. Br Heart J (1982) 0.85
Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog. Br J Pharmacol (1980) 0.75
Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther (1970) 9.54
Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther (1975) 7.96
Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin Pharmacol Ther (1973) 2.14
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs. Drugs (1974) 1.46
Beta-adrenergic receptor blocking drugs in hyperthyroidism. Drugs (1974) 1.22
Serum digoxin in patients with thyroid disease. Br Med J (1975) 1.19
5-Hydroxytryptamine (5-HT) in the whole-blood of patients with depressive illness. Postgrad Med J (1976) 0.94
Inhibition of drug metabolism in man. Drug Metab Dispos (1974) 0.92
Influence of thyroid status on plasma half-life of antipyrine in man. N Engl J Med (1974) 0.90
The kinetics of propylthiouracil in hyperthyroidism. Acta Pharmacol Toxicol (Copenh) (1975) 0.88
The pharmacokinetics of propylthiouracil. Acta Pharmacol Toxicol (Copenh) (1974) 0.85
Echocardiography in chronic heart failure in the community. Q J Med (1993) 7.64
Primary non-compliance with prescribed medication in primary care. BMJ (1993) 6.80
Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Br J Pharmacol (1968) 4.20
Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol (2004) 4.12
Association of road-traffic accidents with benzodiazepine use. Lancet (1998) 4.01
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
The assessment of beta-adrenoceptor blocking drugs in man. Br J Clin Pharmacol (1977) 3.13
The cardio-toxicity of isoprenaline during hypoxia. Br J Pharmacol (1969) 2.94
The clinical pharmacology of mexiletine. Br J Clin Pharmacol (1978) 2.56
Controlled trial of propranolol in thyrotoxicosis. Lancet (1969) 2.54
Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland. BMJ (1996) 2.51
Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology (2000) 2.39
Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ (1997) 2.39
Mobile coronary care and community mortality from myocardial infarction. Lancet (1985) 2.27
Introducing a drug formulary to general practice--effects on practice prescribing costs. J R Coll Gen Pract (1987) 2.24
Persistence of porcine reproductive and respiratory syndrome virus in serum and semen of adult boars. J Vet Diagn Invest (1995) 2.24
Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol (1989) 2.06
Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut (1997) 1.98
The clinical pharmacology of beta adrenergic blocking drugs. J R Coll Physicians Lond (1976) 1.94
Safety of reusing disposable plastic insulin syringes. Lancet (1983) 1.94
A double-blind placebo-controlled trial of theophylline in general practice. Br J Clin Pract (1991) 1.93
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol (1989) 1.88
Is maintenance digoxin necessary in patients with sinus rhythm? Lancet (1979) 1.86
Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med (1994) 1.86
Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia. Pneumococcal Study Group. Med J Aust (1999) 1.83
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother (2000) 1.79
Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther (1977) 1.77
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet (1973) 1.68
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol (1985) 1.67
An epidemiological study of digoxin prescribing in general practice. J R Coll Gen Pract (1986) 1.66
Clinical pharmacokinetics of oral anticoagulants. Clin Pharmacokinet (1979) 1.66
Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. Cardiovasc Res (1976) 1.66
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol (1985) 1.65
Hyperosmolar non-ketoacidotic coma in diabetes. Lancet (1966) 1.65
Nutrients and toxicants in rapeseed meal: a review. J Anim Sci (1984) 1.65
Propranolol and the utilization of radioiodine by the human thyroid gland. Acta Endocrinol (Copenh) (1969) 1.63
Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther (1976) 1.62
The influence of floral display size on selfing rates in Mimulus ringens. Heredity (Edinb) (2004) 1.57
Methicillin-resistant Staphylococcal aureus evolution in Australia over 35 years. Microb Drug Resist (2000) 1.57
Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest (1987) 1.56
Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Australian Group on Antimicrobial Resistance (AGAR) Med J Aust (1996) 1.54
Invasive Haemophilus influenzae infection in the Australian Capital Territory region. Med J Aust (1992) 1.52
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. Thorax (1993) 1.51
beta-Adrenoceptor antagonists and respiratory function. Br J Clin Pharmacol (1978) 1.50
Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade. Br J Clin Pharmacol (1989) 1.48
Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46
Intermittent therapy with corticotrophin. Lancet (1966) 1.46
A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease. Mayo Clin Proc (1992) 1.46
Adverse reactions and interactions with beta-adrenoceptor blocking drugs. Med Toxicol (1987) 1.44
Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline. Br J Clin Pharmacol (1983) 1.44
Gastric teratoma with intramural extension. Pediatr Radiol (1995) 1.39
Digoxin compliance in patients from general practice. Br J Clin Pharmacol (1978) 1.38
Developments in surgical oncology--past, present, and future trends. Med J Aust (1992) 1.38
Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. Br J Clin Pharmacol (1986) 1.38
Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device. Br J Clin Pharmacol (1993) 1.37
Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol (1973) 1.36
Plasma concentrations and the time-course of beta blockade due to propranolol. Clin Pharmacol Ther (1975) 1.36
Brucellosis in Northern Ireland. A serological survey. J Hyg (Lond) (1969) 1.34
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Direct determination of the membrane affinities of individual amino acids. Biochemistry (1996) 1.32
The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Am Rev Respir Dis (1985) 1.31
Measurement of theophylline in plasma by high performance liquid chromatography. Br J Clin Pharmacol (1976) 1.31
Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol (1988) 1.31
Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. Q J Med (1989) 1.31
Detection of porcine reproductive and respiratory syndrome virus in boar semen by PCR. J Clin Microbiol (1995) 1.30
Investigation of diurnal changes in the disposition of theophylline. Br J Clin Pharmacol (1983) 1.29
Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects. Br J Clin Pharmacol (1989) 1.29
Measurement of plasma mexiletine concentrations. Postgrad Med J (1977) 1.28
The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion. J Mol Biol (1999) 1.25
Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol. Clin Pharmacol Ther (1981) 1.23
Theophylline kinetics in relation to age: the importance of smoking. Br J Clin Pharmacol (1980) 1.23
Central effects of beta-adrenoceptor antagonists. Clin Pharmacol Ther (1983) 1.22
Synacthen Depot--Adrenal response in normal subjects and corticotrophin-treated patients. Br Med J (1968) 1.21
Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM (1995) 1.21
Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline. Thorax (1992) 1.21
Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade. Eur J Clin Pharmacol (1989) 1.21
Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis (1989) 1.20
Plasma theophylline concentrations following the oral administration of microcrystalline theophylline and a new sustained-release theophylline preparation to normal subjects. Eur J Clin Pharmacol (1980) 1.20
Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine. Br J Clin Pharmacol (1983) 1.19
Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood. Br J Clin Pharmacol (1988) 1.19
Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients. Thorax (1995) 1.19
A generalized rank-order method for nonparametric analysis of data from exercise science: a tutorial. Res Q Exerc Sport (1999) 1.18
The breasts of "Night": Michelangelo as oncologist. N Engl J Med (2000) 1.18
Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway. Br J Clin Pharmacol (1988) 1.17
A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol. Eur J Clin Pharmacol (1991) 1.17
Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use. Drugs (1979) 1.17
Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease. Br J Clin Pharmacol (1984) 1.15
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Thorax (1995) 1.12
Vagal activity is increased during intravenous isoprenaline infusion in man. Br J Clin Pharmacol (1984) 1.11